We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
989

Sector Composition

Rank Sector Weight
1 Technology 6.08%
2 Financials 6.03%
3 Industrials 5.01%
4 Consumer Discretionary 4.73%
5 Healthcare 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVXL icon
7451
PUT
Anavex Life Sciences
AVXL
$255M
$52K ﹤0.01%
+16,200
New +$63.8K
FSM icon
7452
Fortuna Silver Mines
FSM
$2.55B
$52K ﹤0.01%
10,052
-62,140
-86% -$280K
HEPA
7453
DELISTED
Hepion Pharmaceuticals
HEPA
0
MTNB icon
7454
Matinas BioPharma
MTNB
$1.88M
$52K ﹤0.01%
+895
New +$57.5K
NOTV
7455
DELISTED
Inotiv
NOTV
$52K ﹤0.01%
20,886
+5,287
+34% +$11.8K
OCUL icon
7456
Ocular Therapeutix
OCUL
$1.79B
$52K ﹤0.01%
+11,589
New +$59.2K
SOL
7457
DELISTED
Emeren Group
SOL
$52K ﹤0.01%
+19,597
New +$55.6K
STNG icon
7458
CALL
Scorpio Tankers
STNG
$3.9B
$52K ﹤0.01%
1,720
+390
+29% +$13.1K
GRU
7459
DELISTED
ELEMENTS Linked to the ICE BofAML Commodity Index eXtra Grains Total Return
GRU
$52K ﹤0.01%
+15,479
New +$52.9K
ZOM
7460
DELISTED
Zomedica Corp.
ZOM
$52K ﹤0.01%
+26,090
New +$58K
CGEN icon
7461
Compugen
CGEN
$222M
$51K ﹤0.01%
+20,363
New +$60.6K
ENPH icon
7462
Enphase Energy
ENPH
$4.96B
$51K ﹤0.01%
20,969
-64,863
-76% -$136K
TA
7463
CALL
DELISTED
TravelCenters of America LLC
TA
$51K ﹤0.01%
+2,480
New +$57.6K
VSLR
7464
CALL
DELISTED
VIVINT SOLAR, INC.
VSLR
$51K ﹤0.01%
12,500
-600
-5% -$2.22K
EPE
7465
CALL
DELISTED
EP Energy Corporation
EPE
$51K ﹤0.01%
21,700
-10,800
-33% -$25.8K
BBG
7466
CALL
DELISTED
Bill Barrett Corp
BBG
$51K ﹤0.01%
10,000
-12,200
-55% -$62.4K
AIRI icon
7467
Air Industries Group
AIRI
$13M
$50K ﹤0.01%
2,930
+1,519
+108% +$21.4K
FCEL icon
7468
CALL
FuelCell Energy
FCEL
$1.73B
$50K ﹤0.01%
82
-147
-64% -$102K
UEC icon
7469
PUT
Uranium Energy
UEC
$4.75B
$50K ﹤0.01%
28,100
+16,200
+136% +$22.8K
VVR icon
7470
Invesco Senior Income Trust
VVR
$457M
$50K ﹤0.01%
+11,392
New +$50.2K
JNP
7471
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$50K ﹤0.01%
+10,404
New +$50.6K
HPJ
7472
CALL
DELISTED
Highpower International Inc
HPJ
$50K ﹤0.01%
+13,400
New +$61.4K
CLIR icon
7473
PUT
ClearSign Technologies
CLIR
$24.3M
$49K ﹤0.01%
+1,370
New +$44.7K
OCUL icon
7474
CALL
Ocular Therapeutix
OCUL
$1.79B
$49K ﹤0.01%
10,900
-13,800
-56% -$70.5K
OPCH icon
7475
Option Care Health
OPCH
$3.45B
$49K ﹤0.01%
4,238
-9,053
-68% -$91.4K

Similar funds

Citadel Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Citadel Advisors held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Citadel Advisors deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Citadel Advisors's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Citadel Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Citadel Advisors's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Citadel Advisors opened 1,440 new positions and closed 989 in Q4 2017.
  • Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.